Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...
An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...
The California biotech has drawn partnerships with Eli Lilly and J&J on the promise of its approach to rebalancing the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback